{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "Tardive dystonia",
    "dc:creator": [
        "VAN HARTEN, P. N",
        "KAHN, R. S"
    ],
    "dc:relation": "Schizophrenia bulletin -- Schizophr. bull, CODEN SCZBB3, ISSN 0586-7614, Vol. 25 (4) , pp. 741-748",
    "dc:date": "1999",
    "dc:type": [
        "Text",
        "Article"
    ],
    "dc:language": "English",
    "dc:publisher": "Oxford University Press",
    "dc:format": [
        "print",
        "3 p"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Enzyme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Extrapyramidal syndrome"
        },
        {
            "@xml:lang": "fr",
            "#text": "Hydrolases"
        },
        {
            "@xml:lang": "fr",
            "#text": "Metalloendopeptidases"
        },
        {
            "@xml:lang": "fr",
            "#text": "Mouvement involontaire"
        },
        {
            "@xml:lang": "fr",
            "#text": "Muscle strié pathologie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Peptidases"
        },
        {
            "@xml:lang": "fr",
            "#text": "Système nerveux pathologie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Trouble neurologique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Antagoniste"
        },
        {
            "@xml:lang": "fr",
            "#text": "Article synthèse"
        },
        {
            "@xml:lang": "fr",
            "#text": "Atypique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Bontoxilysin"
        },
        {
            "@xml:lang": "fr",
            "#text": "Complication"
        },
        {
            "@xml:lang": "fr",
            "#text": "Diagnostic différentiel"
        },
        {
            "@xml:lang": "fr",
            "#text": "Dyskinésie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Dystonie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Epidémiologie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Homme"
        },
        {
            "@xml:lang": "fr",
            "#text": "International"
        },
        {
            "@xml:lang": "fr",
            "#text": "Long terme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Neuroleptique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Phénoménologie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Prévalence"
        },
        {
            "@xml:lang": "fr",
            "#text": "Psychotrope"
        },
        {
            "@xml:lang": "fr",
            "#text": "Récepteur dopaminergique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Santé mentale"
        },
        {
            "@xml:lang": "fr",
            "#text": "Santé publique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Tardif"
        },
        {
            "@xml:lang": "fr",
            "#text": "Traitement"
        },
        {
            "@xml:lang": "fr",
            "#text": "Utilisation"
        },
        {
            "@xml:lang": "fr",
            "#text": "Changement médicament"
        },
        {
            "@xml:lang": "en",
            "#text": "Enzyme"
        },
        {
            "@xml:lang": "en",
            "#text": "Extrapyramidal syndrome"
        },
        {
            "@xml:lang": "en",
            "#text": "Hydrolases"
        },
        {
            "@xml:lang": "en",
            "#text": "Metalloendopeptidases"
        },
        {
            "@xml:lang": "en",
            "#text": "Involuntary movement"
        },
        {
            "@xml:lang": "en",
            "#text": "Striated muscle disease"
        },
        {
            "@xml:lang": "en",
            "#text": "Peptidases"
        },
        {
            "@xml:lang": "en",
            "#text": "Nervous system diseases"
        },
        {
            "@xml:lang": "en",
            "#text": "Neurological disorder"
        },
        {
            "@xml:lang": "en",
            "#text": "Antagonist"
        },
        {
            "@xml:lang": "en",
            "#text": "Review"
        },
        {
            "@xml:lang": "en",
            "#text": "Atypical"
        },
        {
            "@xml:lang": "en",
            "#text": "Bontoxilysin"
        },
        {
            "@xml:lang": "en",
            "#text": "Complication"
        },
        {
            "@xml:lang": "en",
            "#text": "Differential diagnostic"
        },
        {
            "@xml:lang": "en",
            "#text": "Dyskinesia"
        },
        {
            "@xml:lang": "en",
            "#text": "Dystonia"
        },
        {
            "@xml:lang": "en",
            "#text": "Epidemiology"
        },
        {
            "@xml:lang": "en",
            "#text": "Human"
        },
        {
            "@xml:lang": "en",
            "#text": "International"
        },
        {
            "@xml:lang": "en",
            "#text": "Long term"
        },
        {
            "@xml:lang": "en",
            "#text": "Neuroleptic"
        },
        {
            "@xml:lang": "en",
            "#text": "Phenomenology"
        },
        {
            "@xml:lang": "en",
            "#text": "Prevalence"
        },
        {
            "@xml:lang": "en",
            "#text": "Psychotropic"
        },
        {
            "@xml:lang": "en",
            "#text": "Dopamine receptor"
        },
        {
            "@xml:lang": "en",
            "#text": "Mental health"
        },
        {
            "@xml:lang": "en",
            "#text": "Public health"
        },
        {
            "@xml:lang": "en",
            "#text": "Late"
        },
        {
            "@xml:lang": "en",
            "#text": "Treatment"
        },
        {
            "@xml:lang": "en",
            "#text": "Use"
        },
        {
            "@xml:lang": "en",
            "#text": "Drug switching"
        },
        {
            "@xml:lang": "es",
            "#text": "Enzima"
        },
        {
            "@xml:lang": "es",
            "#text": "Extrapiramidal síndrome"
        },
        {
            "@xml:lang": "es",
            "#text": "Hydrolases"
        },
        {
            "@xml:lang": "es",
            "#text": "Metalloendopeptidases"
        },
        {
            "@xml:lang": "es",
            "#text": "Movimiento involuntario"
        },
        {
            "@xml:lang": "es",
            "#text": "Músculo estriado patología"
        },
        {
            "@xml:lang": "es",
            "#text": "Peptidases"
        },
        {
            "@xml:lang": "es",
            "#text": "Sistema nervioso patología"
        },
        {
            "@xml:lang": "es",
            "#text": "Trastorno neurológico"
        },
        {
            "@xml:lang": "es",
            "#text": "Antagonista"
        },
        {
            "@xml:lang": "es",
            "#text": "Artículo síntesis"
        },
        {
            "@xml:lang": "es",
            "#text": "Atípico"
        },
        {
            "@xml:lang": "es",
            "#text": "Bontoxilysin"
        },
        {
            "@xml:lang": "es",
            "#text": "Complicación"
        },
        {
            "@xml:lang": "es",
            "#text": "Diagnóstico diferencial"
        },
        {
            "@xml:lang": "es",
            "#text": "Disquinesia"
        },
        {
            "@xml:lang": "es",
            "#text": "Distonía"
        },
        {
            "@xml:lang": "es",
            "#text": "Epidemiología"
        },
        {
            "@xml:lang": "es",
            "#text": "Hombre"
        },
        {
            "@xml:lang": "es",
            "#text": "Internacional"
        },
        {
            "@xml:lang": "es",
            "#text": "Largo plazo"
        },
        {
            "@xml:lang": "es",
            "#text": "Neuroléptico"
        },
        {
            "@xml:lang": "es",
            "#text": "Fenomenología"
        },
        {
            "@xml:lang": "es",
            "#text": "Prevalencia"
        },
        {
            "@xml:lang": "es",
            "#text": "Psicotropo"
        },
        {
            "@xml:lang": "es",
            "#text": "Receptor dopaminérgico"
        },
        {
            "@xml:lang": "es",
            "#text": "Salud mental"
        },
        {
            "@xml:lang": "es",
            "#text": "Salud pública"
        },
        {
            "@xml:lang": "es",
            "#text": "Tardío"
        },
        {
            "@xml:lang": "es",
            "#text": "Tratamiento"
        },
        {
            "@xml:lang": "es",
            "#text": "Utilización"
        },
        "002B02B03: Psycholeptiques: tranquillisant, neuroleptique. / Psycholeptics: tranquillizer, neuroleptic.",
        "770-: Psychologie. Psychanalyse. Psychiatrie / Psychology. Psychoanalysis. Psychiatry",
        "770-E: Psychopharmacologie / Psychopharmacology"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 1218913"
}